Cargando...
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more than 80 % of neonates with a birth weight less than 1,000 g. Methylxanthine therapies, including caffeine and theophylline, are a mainstay in the treatment and prevention of AOP. Despite their frequent use, litt...
Guardado en:
| Publicado en: | Paediatr Drugs |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609880/ https://ncbi.nlm.nih.gov/pubmed/24399614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-013-0063-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|